BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2710685)

  • 1. Therapy-relevant discrepancies between diagnoses of institutional pathologists and experienced hematopathologists in the diagnosis of malignant lymphoma.
    Stel HV; Vroom TM; Blok P; van Heerde P; Meijer CJ
    Pathol Res Pract; 1989 Feb; 184(2):242-7. PubMed ID: 2710685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists.
    Dick F; VanLier S; Banks P; Frizzera G; Witrak G; Gibson R; Everett G; Schuman L; Isacson P; O'Conor G
    J Natl Cancer Inst; 1987 Jun; 78(6):1137-44. PubMed ID: 3473254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yorkshire Regional Lymphoma Histopathology panel: analysis of five years' experience.
    Bird CC; Lauder I; Kellett HS; Chorlton I; Barnes N; Darwin C; Cartwright RA; Boyko R
    J Pathol; 1984 Aug; 143(4):249-58. PubMed ID: 6481524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases.
    Woodruff RD
    Arch Pathol Lab Med; 1981 Nov; 105(11):573-6. PubMed ID: 7027993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic assessment of enlarged superficial lymph nodes by fine needle aspiration.
    Pilotti S; Di Palma S; Alasio L; Bartoli C; Rilke F
    Acta Cytol; 1993; 37(6):853-66. PubMed ID: 8249502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry.
    Strobbe L; van der Schans SA; Heijker S; Meijer JW; Mattijssen EJ; Mandigers CM; de Kievit IM; Raemaekers JM; Hebeda KM; van Krieken JH
    Leuk Lymphoma; 2014 May; 55(5):1018-22. PubMed ID: 23885798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy.
    Fend F; Kremer M
    Pathobiology; 2007; 74(2):133-43. PubMed ID: 17587884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphomas that mimic benign lymphoid lesions: a review of four lymphomas.
    Wilson CS; Chang KL; Weiss LM
    Semin Diagn Pathol; 1995 Feb; 12(1):77-86. PubMed ID: 7770676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Borderline between Hodgkin and non-Hodgkin lymphomas with unfavorable clinical course: a clinical, histological and immunohistochemical analysis of 33 cases within the German Hodgkin Lymphoma Study].
    Bernhards J; Fischer R; Werner M; Hübner K; Schwarze EW; Georgii A
    Verh Dtsch Ges Pathol; 1992; 76():159-63. PubMed ID: 1283250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopathologic discrepancies between referral and review diagnoses: a gap between general pathologists and hematopathologists.
    Chang C; Huang SW; Su IJ; Chang KC
    Leuk Lymphoma; 2014 May; 55(5):1023-30. PubMed ID: 23927394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary diagnosis and REAL/WHO classification of non-Hodgkin's lymphoma by fine-needle aspiration: cytomorphologic and immunophenotypic approach.
    Mourad WA; Tulbah A; Shoukri M; Al Dayel F; Akhtar M; Ali MA; Hainau B; Martin J
    Diagn Cytopathol; 2003 Apr; 28(4):191-5. PubMed ID: 12672094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new system of diagnosis and classification--malignant lymphoma].
    Shirakawa S; Kita K; Ohno T; Miwa H
    Nihon Rinsho; 1992 Jun; 50(6):1200-8. PubMed ID: 1518135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
    Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
    Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomorphology and immunocytochemistry of fine needle aspirates from blastic non-Hodgkin's lymphomas.
    Tani E; Liliemark J; Svedmyr E; Mellstedt H; Biberfeld P; Skoog L
    Acta Cytol; 1989; 33(3):363-71. PubMed ID: 2728790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.